Cargando…

Safety and Outcomes of Amikacin Liposome Inhalation Suspension for Mycobacterium abscessus Pulmonary Disease: A NTM-NET study

Detalles Bibliográficos
Autores principales:	Henriette Zweijpfenning, Sanne Maria, Chiron, Raphael, Essink, Sharon, Schildkraut, Jodie, Akkerman, Onno W., Aliberti, Stefano, Altenburg, Josje, Arets, Bert, van Braeckel, Eva, Delaere, Bénédicte, Gohy, Sophie, Haarman, Eric, Lorent, Natalie, McKew, Genevieve, Morgan, Lucy, Wagner, Dirk, van Ingen, Jakko, Hoefsloot, Wouter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians 2022
Materias:	Chest Infections: Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279646/ https://www.ncbi.nlm.nih.gov/pubmed/35063454 http://dx.doi.org/10.1016/j.chest.2022.01.015

Ejemplares similares

Treatment of severe Mycobacterium avium complex pulmonary disease with adjunctive amikacin and clofazimine versus standard regimen alone: a retrospective study
por: Zweijpfenning, Sanne M.H., et al.
Publicado: (2021)

Amikacin Liposomal Inhalation Suspension in the Treatment of Mycobacterium abscessus Lung Infection: A French Observational Experience
por: Chiron, Raphael, et al.
Publicado: (2022)

Immune defects in patients with pulmonary Mycobacterium abscessus disease without cystic fibrosis
por: Schuurbiers, Milou M.F., et al.
Publicado: (2020)

The epidemiology of nontuberculous mycobacterial pulmonary disease in the Netherlands
por: Schildkraut, Jodie Anne, et al.
Publicado: (2021)

Evaluation of the GenoType NTM-DR assay performance for the identification and molecular detection of antibiotic resistance in Mycobacterium abscessus complex
por: Bouzinbi, Nicolas, et al.
Publicado: (2020)

Inhaled tigecycline is effective against Mycobacterium abscessus in vitro and in vivo
por: Pearce, Camron, et al.
Publicado: (2020)

Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)

Otomastoiditis Caused by Mycobacterium abscessus, the Netherlands
por: van Ingen, Jakko, et al.
Publicado: (2010)

Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease
por: Danho, Rabi, et al.
Publicado: (2022)

RNA Sequencing Elucidates Drug-Specific Mechanisms of Antibiotic Tolerance and Resistance in Mycobacterium abscessus
por: Schildkraut, Jodie A., et al.
Publicado: (2022)

Inducible Resistance to Amikacin in Mycobacterium abscessus Isolated in Beijing, China
por: Zhang, Zhijian, et al.
Publicado: (2022)

Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
por: Portell-Buj, Elena, et al.
Publicado: (2021)

The role of rifampicin within the treatment of Mycobacterium avium pulmonary disease
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Diagnosis and Management of Pulmonary NTM with a Focus on Mycobacterium avium Complex and Mycobacterium abscessus: Challenges and Prospects
por: Hendrix, Christian, et al.
Publicado: (2022)

Subtle immunodeficiencies in nodular–bronchiectatic Mycobacterium avium complex lung disease
por: Bruno, Mariolina, et al.
Publicado: (2020)

Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
por: Palucci, Ivana, et al.
Publicado: (2023)

Disseminated Mycobacterium abscessus infection in a peritoneal dialysis patient
por: Mooren, Vincent H.J.F., et al.
Publicado: (2017)

805. Amikacin Liposome Inhalation Suspension (ALIS) Add-on Therapy for Refractory Mycobacterium avium Complex (MAC) Lung Disease: Effect of In Vitro Amikacin Susceptibility on Sputum Culture Conversion
por: Brown-Elliott, Barbara A, et al.
Publicado: (2018)

Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
por: Yang, Jeng-How, et al.
Publicado: (2022)

Dissemination of Mycobacterium abscessus via global transmission networks
por: Ruis, Christopher, et al.
Publicado: (2021)

Mykobakterien, nichttuberkulöse (NTM)
por: Rüsch-Gerdes, Sabine, et al.
Publicado: (2009)

Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021)

Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
por: Rubino, Christopher M., et al.
Publicado: (2021)

Rapid Detection of Clarithromycin and Amikacin Resistance in Mycobacterium abscessus Complex by High-Resolution Melting Curve Analysis
por: Li, Haoran, et al.
Publicado: (2022)

Challenges of NTM Drug Development
por: Falkinham, Joseph O.
Publicado: (2018)

Whole genome sequencing of Nontuberculous Mycobacterium (NTM) isolates from sputum specimens of co-habiting patients with NTM pulmonary disease and NTM isolates from their environment
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Quality of life in children receiving treatment for Mycobacterium abscessus otomastoiditis
por: Leow, Theresa Y.S., et al.
Publicado: (2022)

Anxiety and depression in Dutch patients with primary ciliary dyskinesia and their caregivers: associations with health-related quality of life
por: Verkleij, Marieke, et al.
Publicado: (2021)

MGIT Enriched Shotgun Metagenomics for Routine Identification of Nontuberculous Mycobacteria: a Route to Personalized Health Care
por: Schildkraut, Jodie A., et al.
Publicado: (2023)

Editorial: NTM—The New Uber-Bugs
por: Dartois, Veronique, et al.
Publicado: (2019)

Antagonism between Front-Line Antibiotics Clarithromycin and Amikacin in the Treatment of Mycobacterium abscessus Infections Is Mediated by the whiB7 Gene
por: Pryjma, Mark, et al.
Publicado: (2017)

Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates
por: Kim, Su-Young, et al.
Publicado: (2021)

Positive Effect of Liposomal Amikacin for Inhalation on Mycobacterium abcessus in Cystic Fibrosis Patients
por: Caimmi, Davide, et al.
Publicado: (2018)

Host Variability in NTM Disease: Implications for Research Needs
por: Swenson, Colin, et al.
Publicado: (2018)

Nontuberculous mycobacteria (NTM): Microbiological, clinical and geographical distribution
por: Sharma, Surendra K.
Publicado: (2020)

Amikacin Liposome Inhalation Suspension for Mycobacterium avium Complex Lung Disease: A 12-Month Open-Label Extension Clinical Trial
por: Winthrop, Kevin L., et al.
Publicado: (2021)

1418. Pharmacokinetics (PK) and Toxicity of Intravenous Amikacin (AMK) Dosed Three Times a Week (TIW) for Treatment of Disseminated Mycobacterium abscessus Infection in Children
por: Tran, M Tuan, et al.
Publicado: (2018)

Host Immune Response and Novel Diagnostic Approach to NTM Infections
por: Abe, Yuko, et al.
Publicado: (2020)

NTM-Based Skill-Aware Knowledge Tracing for Conjunctive Skills
por: Huang, Qiang, et al.
Publicado: (2022)

Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series
por: Namkoong, Ho, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_90t2tu982t7ibcnksqildtk8ku